Medical expenses of urban Chinese patients with stomach cancer during 2002–2011: a hospital-based multicenter retrospective study
Xiao-Jie Sun,
Ju-Fang Shi,
Lan-Wei Guo,
Hui-Yao Huang,
Neng-Liang Yao,
Ji-Yong Gong,
Ya-Wen Sun,
Guo-Xiang Liu,
A-Yan Mao,
Xian-Zhen Liao,
Ya-Na Bai,
Jian-Song Ren,
Xin-Yu Zhu,
Jin-Yi Zhou,
Ling Mai,
Bing-Bing Song,
Yu-Qin Liu,
Lin Zhu,
Ling-Bin Du,
Qi Zhou,
Xiao-Jing Xing,
Pei-An Lou,
Xiao-Hua Sun,
Xiao Qi,
Yuanzheng Wang,
Rong Cao,
Ying Ren,
Li Lan,
Kai Zhang,
Jie He,
Jia-Lin Wang,
Min Dai,
The listed authors are on behalf of the Health Economic Evaluation Working Group, Cancer Screening Program in Urban China (CanSPUC)
Affiliations
Xiao-Jie Sun
School of Health Care Management (key Lab of Health Economics and Policy, National Health Commission), Shandong University
Ju-Fang Shi
Office of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lan-Wei Guo
Department of Cancer Epidemiology, Henan Office for Cancer Control and Research, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital
Hui-Yao Huang
Office of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Neng-Liang Yao
School of Health Care Management (key Lab of Health Economics and Policy, National Health Commission), Shandong University
Ji-Yong Gong
Shandong Academy of Medical Sciences, Shandong Provincial Cancer Hospital Affiliated to Shandong University
Ya-Wen Sun
Shandong Academy of Medical Sciences, Shandong Provincial Cancer Hospital Affiliated to Shandong University
Guo-Xiang Liu
Department of Health Economics, School of Health Management, Harbin Medical University
A-Yan Mao
Public Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences
Xian-Zhen Liao
Hunan Office for Cancer Control and Research, Hunan Provincial Cancer Hospital
Ya-Na Bai
Institute of Epidemiology and Health Statistics, Lanzhou University
Jian-Song Ren
Office of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Xin-Yu Zhu
Office of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Jin-Yi Zhou
Institute of Chronic Non-communicable Diseases Prevention and Control, Jiangsu Provincial Center for Disease Control and Prevention
Ling Mai
Department of Institute of Tumor Research, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital
Bing-Bing Song
Heilongjiang Office for Cancer Control and Research, Affiliated Cancer Hospital of Harbin Medical University
Yu-Qin Liu
Cancer Epidemiology Research Center, Gansu Provincial Cancer Hospital
Lin Zhu
Teaching and Research Department, Affiliated Cancer Hospital of Xinjiang Medical University
Ling-Bin Du
Zhejiang Office for Cancer Control and Research, Zhejiang Cancer Hospital
Qi Zhou
Chongqing Office for Cancer Control and Research, Chongqing Cancer Hospital
Xiao-Jing Xing
Liaoning Office for Cancer Control and Research, Liaoning Cancer Hospital & Institute
Pei-An Lou
Department of Control and Prevention of Chronic Non-communicable Diseases, Xuzhou Center for Disease Control and Prevention
Xiao-Hua Sun
Ningbo Clinical Cancer Prevention Guidance Center
Xiao Qi
Department of Occupational Medicine, Tangshan People’s Hospital
Yuanzheng Wang
Department of Economic Operation, Kailuan General Hospital
Rong Cao
Department of Health Policy and Economic Research, Guangdong Provincial Institute of Public Health
Ying Ren
Urban Office of Cancer Early Detection and Treatment, Tieling Central Hospital
Li Lan
Institute of Chronic disease prevention and control, Harbin Center for Disease Control and Prevention
Kai Zhang
Department of Cancer Prevention, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Jie He
Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Jia-Lin Wang
Shandong Academy of Medical Sciences, Shandong Provincial Cancer Hospital Affiliated to Shandong University
Min Dai
Office of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
The listed authors are on behalf of the Health Economic Evaluation Working Group, Cancer Screening Program in Urban China (CanSPUC)
Abstract Background In China, stomach cancer is the third most common cancer and the third leading cause of cancer death. Few studies have examined Chinese stomach cancer patients’ medical expenses and their associated trends. The Cancer Screening Program in Urban China (CanSPUC) is a Major Public Health Project funded by the central government. Through this project, we have extracted patients’ medical expenses from hospital billing data to examine the costs of the first course treatments (which refers to 2 months before and 10 months after the date of cancer diagnosis) in Chinese patients with stomach cancer and the associated trends. Methods The expense data of 14,692 urban Chinese patients with stomach cancer were collected from 40 hospitals in 13 provinces. We estimated the inflation-adjusted medical expenses per patient during 2002–2011. We described the time trends of medical expenses at the country-level, and those trends by subgroup, and analyzed the compositions of medical expenses. We constructed the Generalized Linear Mixed (GLM) regression model with Poisson distribution to examine the factors that were associated with medical expenses per patient. Results The average medical expenses of the first course treatments were about 43,249 CNY (6851 USD) in 2011, more than twice of that in 2002. The expenses increased by an average annual rate of 7.4%. Longer stay during hospitalization and an increased number of episodes of care are the two main contributors to the expense increase. The upward trend of medical expenses was observed in almost all patient subgroups. Drug expenses accounted for over half of the medical expenses. Conclusions The average medical expenses of the first course (2 months before and 10 months after the date of cancer diagnosis) treatments per stomach cancer patient in urban China in 2011 were doubled during the previous 10 years, and about twice as high as the per capita disposable income of urban households in the same year. Such high expenses indicate that it makes economic sense to invest in cancer prevention and control in China.